ACGL
Arch Capital Group Ltd.
ACGL's fundamentals are mixed: its operating margin rose 7 points to 26%, but revenue fell 3.9%. At 8.9x earnings, it's trading in line with its usual 9.3x. Analysts expect earnings to hold roughly steady.
IREN
IREN Limited
There isn't enough reported data to score IREN yet.
ACGL Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Strong | |
| N/A | |
| N/A |
ACGL's profitability is currently strong, but its revenue is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like ACGL.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
ACGL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.8x | $95.05 | -13% |
| Current | 9x | $109 | — |
| Fair | 9.3x | $113 | +3.8% |
| Forward | 11x | $109 | — |
| Expensive | 12x | $152 | +40% |
Historical ranges are pointers, not guarantees.
ACGL's PE is in its fair range at 8.9x. On analysts' estimates for next year's earnings, today's price would be 11x, in its expensive range.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
ACGL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect ACGL's profitability to improve, but its revenue to decline.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
ACGL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.79 | -20% |
| Q3 2026 | $12.21 | +14% |
| Q2 2026 | $12.77 | +32% |
| Q1 2026 | $13.00 | +33% |
| Q4 2025 | $11.60 | +3.7% |
| Q3 2025 | $10.68 | -28% |
| Q2 2025 | $9.68 | -32% |
| Q1 2025 | $9.75 | -23% |
| Q4 2024 | $11.19 | -3.7% |
ACGL has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
ACGL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $4.7B | -8.9% |
| Q2 2026 | $4.7B | -10% |
| Q1 2026 | $4.5B | -3.3% |
| Q4 2025 | $4.9B | +8.5% |
| Q3 2025 | $5.1B | +8.2% |
| Q2 2025 | $5.2B | +23% |
| Q1 2025 | $4.7B | +19% |
| Q4 2024 | $4.5B | +14% |
ACGL's revenue grew through 2024 and has held roughly level since: $4.7B last quarter, down 8.9% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q4 2021 | 38% | +12 points |
| Q3 2021 | 14% | -7.8 points |
| Q2 2021 | 29% | +7.5 points |
| Q1 2021 | 19% | +23 points |
| Q4 2020 | 27% | +7 points |
| Q3 2020 | 22% | N/A |
| Q2 2020 | 21% | N/A |
| Q1 2020 | -4% | N/A |
ACGL's operating margin was 38% last quarter, up 12 points from the same quarter a year ago.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN has the edge over ACGL on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
ACGL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.7B | -20% |
| Q2 2026 | $1.3B | +18% |
| Q1 2026 | $1.2B | -19% |
| Q4 2025 | $1.4B | -11% |
| Q2 2025 | $1.1B | -26% |
| Q1 2025 | $1.4B | -6.5% |
| Q4 2024 | $1.6B | -5.5% |
| Q2 2024 | $1.5B | +33% |
ACGL has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
ACGL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.1% | -7.4M shares |
| 1 year | -9.2% | -34.7M shares |
| 3 years | -10% | -38M shares |
| 5 years | -14% | -56.5M shares |
| Available history | -17% | -70.2M shares |
ACGL has the edge over IREN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.4B |
| Q2 2026 | $1.2B |
| Q1 2026 | $783M |
| Q4 2025 | $798M |
| Q3 2025 | $732M |
| Q2 2025 | $163M |
| Q1 2025 | $196M |
| Q4 2023 | — |
ACGL spent $4.2B buying back its own shares over the past year.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has 399M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
ACGL Net Leverage
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
ACGL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 69.0 | Neutral |
| Stochastic | 81.6 | Overbought |
ACGL's weekly RSI is 69 (neutral) and its Stochastic is 82 (overbought).
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
ACGL PE vs Financial Services Sector
| Metric | ACGL | Sector median | Relative |
|---|---|---|---|
| PE | 9x | 13x | 31% below |
| PE % | 42 | 63 | 21 pts below |
ACGL is trading at 8.9x earnings, a 31% discount to the Financial Services sector's median of 13x.
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
ACGL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $101.2 | 7.9% above |
| 20 week MA | $100.2 | 9% above |
| 50 week MA | $97.0 | 13% above |
| 100 week MA | $94.1 | 16% above |
| 200 week MA | $90.1 | 21% above |
ACGL has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
ACGL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $42.6 | $34.9 | -18% |
| 2021 | $34.9 | $43.5 | +25% |
| 2022 | $43.5 | $63.4 | +46% |
| 2023 | $63.4 | $74.3 | +17% |
| 2024 | $74.3 | $92.3 | +24% |
| 2025 | $92.3 | $95.9 | +3.8% |
| 2026 YTD | $95.9 | $109.2 | +14% |
ACGL has the edge over IREN on returns for 2026, with the stronger performance.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.